As India rolls out its second phase of immunisation, Covid trial participants are seeking information about their status. But govt has allowed only individual requests.
Govt said Wednesday that those getting the Covid-19 vaccination at private hospitals will have to pay for it, setting the stage for their participation in immunisation drive.
Govt considers the 50+ category to be the 'biggest priority group' in the city, and the numbers are being included in the database on the basis of electoral roll figures.
Cutis-Biotech, a pharmaceutical firm, filed a suit in the civil court claiming it was a prior user of the brandname Covishield, and sought to restrain SII from using the name.
Bharat Biotech and Serum Institute of India have approached Drugs Controller General of India requesting a change in factsheets on their vaccines that rule them out for those on blood thinners.
India last week announced that it will send Covid vaccines under grant assistance to Sri Lanka, Bhutan, Maldives, Bangladesh, Nepal, Myanmar, Seychelles, Afghanistan & Mauritius.
Several of SII's volunteers are healthcare workers who will be eligible for getting the vaccine now. Unblinding phase 3 trial data will let them know if they are already vaccinated.
A stunted middle class may be a direct result of extreme inequality. Folks at the top don’t see teeming masses as a meaningful market, except for utilities, soap, short videos, and personal loans.
Based on inflation figures for the last three months, RBI is expected to look for confirmatory evidence that can mark the beginning of a sustained decline in core inflation.
It is argued that India-Israel ties are moving from buyer–seller dynamic to one focused on joint development & manufacturing partnership, a shift 'more durable' than traditional arms sales.
Don’t blame misfortune. This is colossal incompetence and insensitivity. So bad, heads would have rolled even in the old PSU-era Indian Airlines and Air India.
COMMENTS